HPV-independent vulvar neoplasia: an update on evolving diagnostic criteria

Dr. Stephanie Skala reviews the past and (evolving) present categories of HPV-independent vulvar neoplasia, with emphasis on challenging differential diagnoses and key pathologic features of HPV-independent vulvar intraepithelial neoplasia.

Description

Recorded on October 10, 2023

This recording is available only for IGCS member's as part of member benefits. The webinar will be recorded and available for IGCS members. If you are not a member of IGCS, we invite you to join today, see additional membership information below.

To register, please log into your already existing IGCS member account. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

Faculty Information

	Stephanie L. Skala, MD Clinical Assistant Professor of Pathology Gynecologic Pathology Fellowship Director Director of Surgical Pathology Director of Histology and Frozen Section Laboratories Michigan Medicine \| University of Michigan USA
	Adrian Suarez, MD Moderator Surgical Pathology Director The Ohio State University Wexner Medical Center USA

Member Benefit

Not an IGCS member? Join IGCS today and be a part of the leading global society advancing gynecologic cancer care around the world. In addition to complimentary valuable educational resources and training opportunities, you will also be supporting the society’s mission to enhance the care of women with gynecologic cancer worldwide through education and training and public awareness. Click here to learn more about IGCS member benefits.

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

Uterine mesenchymal neoplasms: new and evolving entities

In this session, we will review new and evolving uterine mesenchymal entities as well as biomarker and molecular assays to aid in these diagnoses.

Free

Uterine mesenchymal neoplasms: new and evolving entities - Webinar

Free

Obstacles and solutions for worldwide implementation of the Molecular Endometrial Carcinoma Classification

Dr. Tjalling Bosse reviews why, when, and how to implement molecular classification of endometrial carcinoma.

Free

Pathology Corner

The purpose of this page is to streamline all pathology related education curated specifically for gynecologic oncologists.

Free

International Gynecologic Cancer Society and International Journal of Gynecological Cancer Evidence-Based Medicine for Gynecological Oncology Curriculum (EBM on the GO)

Evidence based medicine (EBM) is defined as the process of systematically finding, appraising, and applying current research to make clinical decisions. EBM integrates clinical expertise with the best available evidence and patients’ values & preferences.

Free

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.

Free

Surgical Film Library

Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.

Free

Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer

This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.

Free

IGCS 2024 Endometrial Cancer Master Session

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

Free

Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm

Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.

Free